Clinical Trial Update: Post-line Treatment With Teniposide for c-Myc-driven Extensive-stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating post-line treatment with teniposide for c-Myc-driven extensive-stage small cell lung cancer; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer
• Lung Neoplasms
• Small Cell Lung Cancer

Drugs mentioned

• Teniposide (teniposide)

Snippet

Sponsor: Shanghai Pulmonary Hospital, Shanghai, China | Conditions: Extensive-stage Small Cell Lung Cancer (ES-SCLC), Thoracic Neoplasms | Phase 2 | Status: RECRUITING